InsiderTrades

Form 4 for AVNT AVIENT CORP

Accepted 2024-01-09 00:00:00 ET · period of report 2024-01-08 · accession 0001127602-24-001134 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-01-09 2024-01-08 AVNT Rathbun Joel R. SVP, Mergers, Acquisitions D - Sale to Iss $38.55 -2,259 5,475 -29% -$87.1K
D 2024-01-09 2024-01-08 AVNT Rathbun Joel R. SVP, Mergers, Acquisitions M - OptEx $35.07 +2,400 7,734 +45% +$84.2K
D 2024-01-09 2024-01-08 AVNT Rathbun Joel R. SVP, Mergers, Acquisitions M - OptEx $0.00 -2,400 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-01-08 D D 2,259 $38.55 5,475 D — —
2 Common Common Stock 2024-01-08 M A 2,400 $35.07 7,734 D — —
3 Derivative Stock Appreciation Rights 2024-01-08 M D 2,400 $0.00 0 D $35.07 · — to 2024-02-11 2,400 Common Stock (F2) SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $35.07 per share and no more than one-third of the grant can vest per year during the first three years.